JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 2 214-221
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howman-Giles, R.
Right arrow Articles by Uren, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howman-Giles, R.
Right arrow Articles by Uren, R.

Hepatobiliary Scintigraphy in a Pediatric Population: Determination of Hepatic Extraction Fraction by Deconvolution Analysis

Robert Howman-Giles, Anne Moase, Kevin Gaskin and Roger Uren

Departments of Nuclear Medicine and Gastroenterology, The Children's Hospital, Champerdown, Australia

Correspondence: For correspondence contact: Dr. Robert Howman-Giles, FRACP, Department of Nuclear Medicine, The Children's Hospital, Champerdown NSW 2050, Australia.

ABSTRACT

A study was performed to assess the feasibility of measuring the hepatic extraction fraction (HEF) and hepatic half clearance time (HCT) in pediatric patients with a variety of hepatobiliary diseases. There were 45 children categorized into four groups: normal 12; obstruction 9; hepatocellular disease (HCD) 16 and miscellaneous 8. In the normal patients, the mean HEF was 99% ± 3.6% and the HCT was 23.6 ± 7.7 min. In the two disease categories, hepatocellular disease and obstruction, there was a wide range of HEF 15%–84% and 25%–100%, respectively. This reflected the varying degrees of liver dysfunction and/or cholestasis. The average results of HEF for the HCD group was significantly lower than controls, and the greatest difference of the HCD group and other disease groups was with the miscellaneous group. This was not, however, different from the obstructive group. There was, however, a large overlap of results, and differentiation between the disease groups was not possible. HCT from the disease groups also showed a prolonged average clearance when compared to normals, although this was not significant when the p value was adjusted for multiple comparisons. The normal HCT was 23.6 ± 7.7 min, whereas the hepatobiliary disease groups ranged from 20 to 714 min. Again, there was considerable overlap of results in the disease groups. These functional parameters are feasible and applicable in the pediatric population.

FOOTNOTES

Reprints not available.




This article has been cited by other articles:


Home page
JCOHome page
M. Michael, M. Thompson, R. J. Hicks, P. L. Mitchell, A. Ellis, A. D. Milner, J. Di Iulio, A. M. Scott, V. Gurtler, J. M. Hoskins, et al.
Relationship of Hepatic Functional Imaging to Irinotecan Pharmacokinetics and Genetic Parameters of Drug Elimination
J. Clin. Oncol., September 10, 2006; 24(26): 4228 - 4235.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.